Report of Foreign Issuer (6-k)
May 10 2019 - 5:02PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER
PURSUANT TO RULE 13a-16 OR 15d-16
UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of May 2019
Commission File Number 001-34566
China Biologic Products Holdings, Inc.
(Exact name of registrant as specified in
its charter)
18th Floor, Jialong International Building,
19 Chaoyang Park Road
Chaoyang District, Beijing 100125
People’s Republic of China
(+86) 10-6598-3111
(Address of principal executive office)
Indicate by check mark whether the registrant
files or will file annual reports under cover of Form 20-F or Form 40-F. Form 20-F
x
Form 40-F
¨
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Note
: Regulation S-T Rule 101(b)(1)
only permits the submission in paper of a Form 6-K if submitted solely to provide an attached annual report to security holders.
Indicate by check mark if the registrant is
submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
Note:
Regulation S-T Rule 101(b)(7)
only permits the submission in paper of a Form 6-K if submitted to furnish a report or other document that the registrant foreign
private issuer must furnish and make public under the laws of the jurisdiction in which the registrant is incorporated, domiciled
or legally organized (the registrant’s “home country”), or under the rules of the home country exchange on which
the registrant’s securities are traded, as long as the report or other document is not a press release, is not required to
be and has not been distributed to the registrant’s security holders, and, if discussing a material event, has already been
the subject of a Form 6-K submission or other Commission filing on EDGAR.
Adoption of 2019 Equity Incentive Plan
On May 10, 2019, the board of directors of China Biologic Products
Holdings, Inc. adopted the China Biologic Products Holdings, Inc. 2019 Equity Incentive Plan (the “2019 Plan”), effective
immediately. The copy of the 2019 Plan is included as Exhibit 99.1 to this Form 6-K.
SIGNATURES
Pursuant to the requirements
of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned
hereunto duly authorized.
|
|
CHINA BIOLOGIC PRODUCTS HOLDINGS, INC.
|
|
|
|
Date:
|
May 10, 2019
|
|
By:
|
/s/ Joseph Chow
|
|
|
|
|
Name:
|
Joseph Chow
|
|
|
|
|
Title:
|
Chairman of the Board of Directors
|
EXHIBIT INDEX
Exhibit Number
|
|
Description
|
99.1
|
|
China Biologic Products Holdings, Inc. 2019 Equity Incentive Plan
|
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Aug 2024 to Sep 2024
China Bioligic Products (NASDAQ:CBPO)
Historical Stock Chart
From Sep 2023 to Sep 2024